PPAR-γ Agonist GW1929 Targeted to Macrophages with Dendrimer–Graphene Nanostars Reduces Liver Fibrosis and Inflammation
Open Access
- 10 May 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (5) , 1452
Abstract
Macrophages play essential roles during the progression of chronic liver disease. They actively participate in the response to liver damage and in the balance between fibrogenesis and regression. The activation of the PPARγ nuclear receptor in macrophages has traditionally been associated with an anti-inflammatory phenotype. However, there are no PPARγ agonists with high selectivity for macrophages, and the use of full agonists is generally discouraged due to severe side effects. We designed dendrimer–graphene nanostars linked to a low dose of the GW1929 PPARγ agonist (DGNS-GW) for the selective activation of PPARγ in macrophages in fibrotic livers. DGNS-GW preferentially accumulated in inflammatory macrophages in vitro and attenuated macrophage pro-inflammatory phenotype. The treatment with DGNS-GW in fibrotic mice efficiently activated liver PPARγ signaling and promoted a macrophage switch from pro-inflammatory M1 to anti-inflammatory M2 phenotype. The reduction of hepatic inflammation was associated with a significant reduction in hepatic fibrosis but did not alter liver function or hepatic stellate cell activation. The therapeutic antifibrotic utility of DGNS-GW was attributed to an increased expression of hepatic metalloproteinases that allowed extracellular matrix remodeling. In conclusion, the selective activation of PPARγ in hepatic macrophages with DGNS-GW significantly reduced hepatic inflammation and stimulated extracellular matrix remodeling in experimental liver fibrosis.Keywords
Funding Information
- Ministerio de Ciencia e Innovación (MCIN/AEI/10.13039/501100011033, RTI2018-094734-B-C21, PID2021-123426OB-I00, RYC2018-0Z23971-I, PRE2019-088097, FPU19/03323, RED2022-134485-T, 2021 SGR 00881)
- Ministerio de Ciencia, Innovación y Universidades (MCIN/AEI/10.13039/501100011033, RTI2018-094734-B-C21, PID2021-123426OB-I00, RYC2018-0Z23971-I, PRE2019-088097, FPU19/03323, RED2022-134485-T, 2021 SGR 00881)
- Ministerio de Ciencia, Innovación y Universidades (MCIN/AEI/10.13039/501100011033, RTI2018-094734-B-C21, PID2021-123426OB-I00, RYC2018-0Z23971-I, PRE2019-088097, FPU19/03323, RED2022-134485-T, 2021 SGR 00881)
- Ministerio de Ciencia, Innovación y Universidades (MCIN/AEI/10.13039/501100011033, RTI2018-094734-B-C21, PID2021-123426OB-I00, RYC2018-0Z23971-I, PRE2019-088097, FPU19/03323, RED2022-134485-T, 2021 SGR 00881)
- Instituto de Salud Carlos III. RedFibro (MCIN/AEI/10.13039/501100011033, RTI2018-094734-B-C21, PID2021-123426OB-I00, RYC2018-0Z23971-I, PRE2019-088097, FPU19/03323, RED2022-134485-T, 2021 SGR 00881)
- Programa Estatal del Plan Estatal de Investigación Científica, Técnica y de Innovación 2021–2023 (MCIN/AEI/10.13039/501100011033, RTI2018-094734-B-C21, PID2021-123426OB-I00, RYC2018-0Z23971-I, PRE2019-088097, FPU19/03323, RED2022-134485-T, 2021 SGR 00881)
- Consolidated Research Group of the Generalitat de Catalunya AGAUR (MCIN/AEI/10.13039/501100011033, RTI2018-094734-B-C21, PID2021-123426OB-I00, RYC2018-0Z23971-I, PRE2019-088097, FPU19/03323, RED2022-134485-T, 2021 SGR 00881)
This publication has 55 references indexed in Scilit:
- Anti-inflammatory properties of a dual PPARgamma/alpha agonist muraglitazar in in vitro and in vivomodelsArthritis Research & Therapy, 2013
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Nox2-derived ROS in PPARγ signaling and cell-cycle progression of lung alveolar epithelial cellsFree Radical Biology and Medicine, 2011
- Effects of 15d‐PGJ2‐loaded poly(D,L‐lactide‐co‐glycolide) nanocapsules on inflammationBritish Journal of Pharmacology, 2010
- Control of Macrophage Activation and Function by PPARsCirculation Research, 2010
- In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-αJournal of Clinical Investigation, 2009
- Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNANature, 2008
- Regulation of PPARγ function by TNF-αBiochemical and Biophysical Research Communications, 2008
- Regression of Fibrosis after Chronic Stimulation of Cannabinoid CB2 Receptor in Cirrhotic RatsThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007